Metabolomics Services Market, By Type of Technique (Detection Techniques, Separation Techniques), By Type of Service (Targeted Metabolomics, Untargeted Metabolomics, Metabolite Profiling, Biomarker Discovery, and Other Services), By Application (Drug Disc

The Global Metabolomics Services Market is estimated to be valued at USD 3.21 Bn in 2025 and is expected to reach USD 7.31 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 12.5% from 2025 to 2032. Metabolomics is the scientific study of chemical processes involving metabolites, which are small molecule substrates, intermediates, and products of metabolism. Metabolomics helps researchers gain a deeper understanding of an organism's metabolic responses. The global metabolomics services market is expected to grow significantly in the coming years due to growing application of metabolomics in personalized medicine, drug discovery and development, biomarker discovery, nutrition and energy, and other industrial applications. Metabolomics enables comprehensive metabolic profiling to identify disease biomarkers and therapeutic agents.

Market Dynamics:

The global metabolomics services market is driven by rising research and development expenditure in the pharmaceutical and biotechnology industries, increasing prevalence of cancer and other chronic diseases, growing focus on personalized medicine, and technological advancements in analytical instruments used for metabolomics. However, high costs associated with metabolomics studies and lack of skilled professionals are restraining the market growth. Emerging economies offer lucrative opportunities for market players due to improving healthcare infrastructure and increasing investments in healthcare research in these regions.

Key Features of the Study:

• This report provides in-depth analysis of the global metabolomics services market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global metabolomics services market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Agilent Technologies, Thermo Fisher Scientific, Waters Corporation, Bruker Corporation, Merck KGaA, PerkinElmer, Danaher Corporation, Bio-Rad Laboratories, Shimadzu Corporation, Human Metabolome Technologies, Inc., Metabolon, Inc., LECO Corporation, Scion Instruments, DANI Instruments S.p.A., and GL Sciences
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global metabolomics services market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global metabolomics services market

• By Type of Technique Insights (Revenue, USD Bn, 2020 - 2032)
• Detection Techniques
• Nuclear Magnetic Resonance Spectroscopy (NMR)
• Mass Spectrometry (MS)
• Separation Techniques
• Gas Chromatography (GC)
• Capillary Electrophoresis (CE)
• Liquid Chromatography (LC)
• Others (Supercritical Fluid Chromatography, Ion Mobility Spectrometry, etc.)
• By Type of Service Insights (Revenue, USD Bn, 2020 - 2032)
• Targeted Metabolomics
• Untargeted Metabolomics
• Metabolite Profiling
• Biomarker Discovery
• Other Services
• By Application Insights (Revenue, USD Bn, 2020 - 2032)
• Drug Discovery
• Toxicology Testing
• Biomarker Discovery
• Nutritional Research
• Disease Diagnosis
• Other Applications
• By End User Insights (Revenue, USD Bn, 2020 - 2032)
• Academic and Research Institutes
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations (CROs)
• Diagnostic Laboratories
• Others
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
• North America
• U.S.
• Canada
• Latin America
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Europe
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• GCC Countries
• Israel
• Rest of Middle East
• Africa
• South Africa
• North Africa
• Central Africa
• Key Players Insights
• Agilent Technologies
• Thermo Fisher Scientific
• Waters Corporation
• Bruker Corporation
• Merck KGaA
• PerkinElmer
• Danaher Corporation
• Bio-Rad Laboratories
• Shimadzu Corporation
• Human Metabolome Technologies, Inc.
• Metabolon, Inc.
• LECO Corporation
• Scion Instruments
• DANI Instruments S.p.A.
• GL Sciences